Akorn Inc (AKRX) Stock Price & Overview
NASDAQ:AKRX
The current stock price of AKRX is 0.09 null. Today AKRX is down by -51.01%. In the past month the price decreased by -57.14%. In the past year, price decreased by -97.82%.
AKRX Key Statistics
- Market Cap
- 11.984M
- P/E
- 0.64
- Fwd P/E
- N/A
- EPS (TTM)
- 0.14
- Dividend Yield
- N/A
AKRX Stock Performance
AKRX Stock Chart
AKRX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AKRX. When comparing the yearly performance of all stocks, AKRX is a bad performer in the overall market: 99.96% of all stocks are doing better.
AKRX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AKRX. AKRX has a medium profitability rating, but doesn't score so well on its financial health evaluation.
AKRX Earnings
AKRX Forecast & Estimates
AKRX Financial Highlights
Over the last trailing twelve months AKRX reported a non-GAAP Earnings per Share(EPS) of 0.14000000000000004. The EPS increased by 122.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -55.64% | ||
| ROA | -38.88% | ||
| ROE | N/A | ||
| Debt/Equity | -1.1 |
AKRX Ownership
About AKRX
Company Profile
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Company Info
Akorn Inc
1925 WEST FIELD COURT SUITE 300
LAKE FOREST IL 60045
CEO: Douglas S. Boothe
Phone: 847-279-6100
Akorn Inc / AKRX FAQ
Can you describe the business of Akorn Inc?
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
What is the current price of AKRX stock?
The current stock price of AKRX is 0.09 null. The price decreased by -51.01% in the last trading session.
What is the dividend status of Akorn Inc?
AKRX does not pay a dividend.
What is the ChartMill rating of Akorn Inc stock?
AKRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.